Skip to content

Comparison of two kind of drugs in the treatment of asthma

Randomized clinical trial of comparing oral and inhalant corticosteroids in treatment of mild to moderate attack of asthma in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013101214988N1
Enrollment
60
Registered
2013-11-05
Start date
2013-07-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma. Asthma

Interventions

Treatment - Drugs
Intervention 1: First group will be treated with Salbutamol spray (2 puffs every four hours for 48 hours, each puff contains 100 micro grams of the drug) plus oral prednisolon (2 milligrams per each k
First group will be treated with Salbutamol spray (2 puffs every four hours for 48 hours, each puff contains 100 micro grams of the drug) plus oral prednisolon (2 milligrams per each kilograms of body
Second group will be treated with Salbutamol spray (2 puffs every four hours for 48 hours, each puff contains 100 micro grams of the drug) plus Budesonide spray (2 puffs every 12 hours, for one week,

Sponsors

Vice chancellor for research, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 14 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Having mild to moderate asthma attack; Age between 5 to 14 years old. Exclusion criteria: Unwillingness to participate in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Forced expiratory volume in the first second. Timepoint: In the first and seventh day of the study. Method of measurement: By using spirometry device.;FEV1/FVC. Timepoint: In the first and seventh day of the study. Method of measurement: By using spirometry device.;Diurnal symptoms of the disease. Timepoint: In the first, third and seventh day of the study. Method of measurement: By examiner.;Nocturnal symptoms of the disease. Timepoint: In the first, third and seventh day of the study. Method of measurement: By examiner.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Masoumeh Ghasempour

Tabriz Children Hospital

masoumeh_gh_a@yahoo.com+98 41 1526 2255

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026